Sonoma Pharmaceuticals
SNOA
#10919
Rank
A$8.75 M
Marketcap
A$1.83
Share price
-1.50%
Change (1 day)
-73.76%
Change (1 year)

Earnings for Sonoma Pharmaceuticals (SNOA)

Earnings in 2026 (TTM): -A$3.7 Million

According to Sonoma Pharmaceuticals's latest financial reports the company's current earnings are A$19.52 Million. In 2025 the company made an earning of -A$3.87 Million, an increase over its 2024 earnings that were of -A$6.23 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sonoma Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$3.7 Million-4.32%
2025 -A$3.87 Million-38.02%
2024 -A$6.23 Million0.54%
2023 -A$6.2 Million-31.5%
2022 -A$9.05 Million16.86%
2021 -A$7.74 Million194.32%
2020 -A$2.63 Million-58.76%
2019 -A$6.38 Million-65.66%
2018 -A$18.57 Million4.84%
2017 -A$17.72 Million-2.17%
2016 -A$18.11 Million32.12%
2015 -A$13.71 Million-307.74%
2014 A$6.59 M-197.5%
2013 -A$6.77 Million
2010 -A$10.58 Million-14.02%
2009 -A$12.3 Million-57.28%
2008 -A$28.78 Million-8.03%
2007 -A$31.3 Million3.85%
2006 -A$30.14 Million39.31%
2005 -A$21.63 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.32 Billion 9,202.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$25.35 Million 637.75%๐Ÿ‡บ๐Ÿ‡ธ USA